Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.10% | 125.14 | 0.0% | $2517.24m | |
| BNGO | BioNano Genomics, Inc. | -11.93% | 8.05 | 0.0% | $1626.30m | |
| GILD | Gilead Sciences, Inc. | 1.37% | 67.99 | 1.0% | $696.88m | |
| AMGN | Amgen, Inc. | 1.65% | 252.36 | 1.3% | $574.64m | |
| CRSP | CRISPR Therapeutics AG | -4.30% | 189.77 | 0.6% | $516.52m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.57% | 542.27 | 2.7% | $477.27m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.61% | 157.74 | 2.0% | $471.04m | |
| NVAX | Novavax, Inc. | -2.31% | 125.05 | 92.9% | $463.88m | |
| ILMN | Illumina, Inc. | 3.42% | 403.54 | 3.5% | $395.72m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.04% | 96.76 | 13.8% | $351.95m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.07% | 236.70 | 1.9% | $351.25m | |
| BIIB | Biogen, Inc. | -1.30% | 270.28 | 1.7% | $328.68m | |
| BNTX | BioNTech SE | -1.40% | 103.23 | 0.0% | $308.28m | |
| OCGN | Ocugen, Inc. | -4.70% | 2.23 | 0.0% | $294.71m | |
| PACB | Pacific Biosciences of California, Inc. | -4.02% | 38.59 | 7.4% | $258.16m |
Company Profile
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.